We are live on ! Find out more
CCM

Copeland Capital Management Portfolio holdings

AUM $4.5B
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+18.67%
3 Year Est. Return
+43.33%
5 Year Est. Return
+60.9%
10 Year Est. Return
+320.99%
AUM
$895M
AUM Growth
+$74.4M
Cap. Flow
+$44.9M
Cap. Flow %
5.01%
Top 10 Hldgs %
21.74%
Holding
205
New
24
Increased
108
Reduced
31
Closed
16

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$16.3M
2
ABT icon
Abbott
ABT
+$10.8M
3
NOV icon
NOV
NOV
+$3.64M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$2.87M
5
NEU icon
NewMarket
NEU
+$2.05M

Sector Composition

Rank Sector Weight
1 Industrials 15.85%
2 Energy 15.71%
3 Healthcare 13.05%
4 Financials 9.89%
5 Consumer Discretionary 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
26
Lockheed Martin
LMT
$132B
$16M 1.78%
99,330
+2,192
+2% +$356K
TROW icon
27
T. Rowe Price
TROW
$25.6B
$15.7M 1.76%
186,300
+7,244
+4% +$591K
SLH
28
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
$15.6M 1.74%
232,078
+228,601
+6,575% +$14.9M
GWW icon
29
W.W. Grainger
GWW
$64B
$15.6M 1.74%
61,200
+4,121
+7% +$1.05M
NDSN icon
30
Nordson
NDSN
$16.4B
$15.5M 1.74%
193,859
+19,475
+11% +$1.5M
KMI icon
31
Kinder Morgan
KMI
$70.5B
$15.2M 1.7%
419,094
+34,161
+9% +$1.15M
BAX icon
32
Baxter International
BAX
$13.8B
$15.1M 1.69%
384,342
+13,285
+4% +$531K
SU icon
33
Suncor Energy
SU
$78.8B
$15M 1.68%
352,153
-48,114
-12% -$1.87M
NOV icon
34
NOV
NOV
$6.93B
$14.9M 1.66%
180,670
-48,928
-21% -$3.64M
CRR
35
DELISTED
Carbo Ceramics Inc.
CRR
$14.9M 1.66%
96,460
+10,607
+12% +$1.46M
LAZ icon
36
Lazard
LAZ
$4.09B
$14.7M 1.64%
285,266
+12,044
+4% +$593K
NEU icon
37
NewMarket
NEU
$7.97B
$14.5M 1.62%
37,019
-5,320
-13% -$2.05M
PETM
38
DELISTED
PETSMART INC
PETM
$14.4M 1.61%
241,063
+21,964
+10% +$1.39M
OHI icon
39
Omega Healthcare
OHI
$15B
$14.3M 1.59%
386,875
+18,337
+5% +$654K
XLNX
40
DELISTED
Xilinx Inc
XLNX
$14M 1.57%
296,276
+41,694
+16% +$2.01M
ITC
41
DELISTED
ITC HOLDINGS CORP
ITC
$13.7M 1.54%
376,659
+787
+0.2% +$29.1K
HD icon
42
Home Depot
HD
$332B
$13.5M 1.51%
166,758
+14,944
+10% +$1.18M
MJN
43
DELISTED
Mead Johnson Nutrition Company
MJN
$13.4M 1.5%
144,076
+18,604
+15% +$1.63M
ENB icon
44
Enbridge
ENB
$121B
$13.3M 1.49%
280,110
+15,930
+6% +$754K
TJX icon
45
TJX Companies
TJX
$176B
$13.2M 1.48%
497,242
+57,460
+13% +$1.64M
NUS icon
46
Nu Skin
NUS
$254M
$12.7M 1.42%
171,936
+55,111
+47% +$4.34M
CLB icon
47
Core Laboratories
CLB
$477M
$12.1M 1.35%
72,381
+19,815
+38% +$3.53M
COST icon
48
Costco
COST
$423B
$11.2M 1.25%
96,839
-2,293
-2% -$263K
CAT icon
49
Caterpillar
CAT
$373B
$11M 1.23%
101,016
+5,762
+6% +$605K
CHE icon
50
Chemed
CHE
$7.1B
$10.7M 1.19%
114,092
+5,589
+5% +$496K

Similar funds

Copeland Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Copeland Capital Management held 205 positions worth $895M, up 9.1% from $821M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Copeland Capital Management deployed $44.9M of net new capital in Q2 2014, opening 24 new positions and adding to 108 existing holdings. Its largest new stake was DNOW Inc: 37,070 shares worth $1.34M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 15% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Accenture, an estimated $16.3M trimmed.

  • Copeland Capital Management's largest Q2 2014 buy was DNOW Inc: 37,070 shares worth $1.34M.
  • Copeland Capital Management added most to UnitedHealth in Q2 2014, an estimated $15M increase.
  • Copeland Capital Management's biggest Q2 2014 reduction was Accenture, cutting an estimated $16.3M.
  • Copeland Capital Management fully exited Abbott in Q2 2014, selling an estimated $10.8M.
  • Copeland Capital Management's ten largest holdings make up 22% of its $895M portfolio in Q2 2014.
  • Copeland Capital Management opened 24 new positions and closed 16 in Q2 2014.
  • Copeland Capital Management's portfolio value rose 9.1% quarter-over-quarter to $895M.

Based on Copeland Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.